177 related articles for article (PubMed ID: 23263159)
1. Multivalent glyco(cyclo)peptides.
Galan MC; Dumy P; Renaudet O
Chem Soc Rev; 2013 Jun; 42(11):4599-612. PubMed ID: 23263159
[TBL] [Abstract][Full Text] [Related]
2. Multivalent glycocyclopeptides: toward nano-sized glycostructures.
Daskhan GC; Berthet N; Thomas B; Fiore M; Renaudet O
Carbohydr Res; 2015 Mar; 405():13-22. PubMed ID: 25498201
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic glycosylation of multivalent scaffolds.
Bojarová P; Rosencrantz RR; Elling L; Křen V
Chem Soc Rev; 2013 Jun; 42(11):4774-97. PubMed ID: 23348496
[TBL] [Abstract][Full Text] [Related]
4. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
[TBL] [Abstract][Full Text] [Related]
5. A unified strategy for the synthesis of mucin cores 1-4 saccharides and the assembled multivalent glycopeptides.
Pett C; Schorlemer M; Westerlind U
Chemistry; 2013 Dec; 19(50):17001-10. PubMed ID: 24307362
[TBL] [Abstract][Full Text] [Related]
6. Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.
Pifferi C; Berthet N; Renaudet O
Biomater Sci; 2017 May; 5(5):953-965. PubMed ID: 28275765
[TBL] [Abstract][Full Text] [Related]
7. Glycopeptides and -Mimetics to Detect, Monitor and Inhibit Bacterial and Viral Infections: Recent Advances and Perspectives.
Behren S; Westerlind U
Molecules; 2019 Mar; 24(6):. PubMed ID: 30871155
[TBL] [Abstract][Full Text] [Related]
8. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
9. Discovery and design of carbohydrate-based therapeutics.
Cipolla L; Araújo AC; Bini D; Gabrielli L; Russo L; Shaikh N
Expert Opin Drug Discov; 2010 Aug; 5(8):721-37. PubMed ID: 22827796
[TBL] [Abstract][Full Text] [Related]
10. Synthetic glycopeptides for the development of cancer vaccines.
Liakatos A; Kunz H
Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
[TBL] [Abstract][Full Text] [Related]
11. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
12. Clustered carbohydrates in synthetic vaccines.
Peri F
Chem Soc Rev; 2013 Jun; 42(11):4543-56. PubMed ID: 23250562
[TBL] [Abstract][Full Text] [Related]
13. Mucin-type O-glycosylation--putting the pieces together.
Jensen PH; Kolarich D; Packer NH
FEBS J; 2010 Jan; 277(1):81-94. PubMed ID: 19919547
[TBL] [Abstract][Full Text] [Related]
14. Glyconanoparticles as multifunctional and multimodal carbohydrate systems.
Marradi M; Chiodo F; García I; Penadés S
Chem Soc Rev; 2013 Jun; 42(11):4728-45. PubMed ID: 23288339
[TBL] [Abstract][Full Text] [Related]
15. Glycoclusters on oligonucleotide and PNA scaffolds: synthesis and applications.
Spinelli N; Defrancq E; Morvan F
Chem Soc Rev; 2013 Jun; 42(11):4557-73. PubMed ID: 23254681
[TBL] [Abstract][Full Text] [Related]
16. Multivalent gold glycoclusters: high affinity molecular recognition by bacterial lectin PA-IL.
Reynolds M; Marradi M; Imberty A; Penadés S; Pérez S
Chemistry; 2012 Apr; 18(14):4264-73. PubMed ID: 22362615
[TBL] [Abstract][Full Text] [Related]
17. [The degradation of glycoproteins with lithium borohydride. Isolation and analysis of O-glycopeptides with reduced C-terminal amino acid residue].
Arbatskiĭ NP; Likhosherstov LM; Serebriakova MV; Brusov OS; Shibaev VN; Derevitskaia VA; Kochetkov NK
Bioorg Khim; 2000 Jan; 26(1):51-60. PubMed ID: 10806552
[TBL] [Abstract][Full Text] [Related]
18. Synthetic antitumor vaccines containing MUC1 glycopeptides with two immunodominant domains-induction of a strong immune response against breast tumor tissues.
Gaidzik N; Kaiser A; Kowalczyk D; Westerlind U; Gerlitzki B; Sinn HP; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2011 Oct; 50(42):9977-81. PubMed ID: 21910197
[TBL] [Abstract][Full Text] [Related]
19. Synthetic glycopeptides and glycoproteins as tools for biology.
Pratt MR; Bertozzi CR
Chem Soc Rev; 2005 Jan; 34(1):58-68. PubMed ID: 15643490
[TBL] [Abstract][Full Text] [Related]
20. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
